Author:
Kamil Ali,Sami Shukur Wasan,Assan AL-Dujaili Arafat H
Abstract
Background:Schizophrenia is mental illness described by atypical behavior and a reduced ability to understanding truth. Symptom include false beliefs, confused thinking unclear or, hearing voice and other People do not, reduced emotional expression, social engagement and lack of motivation. Schizophrenia patient often have other mental health problems like depressive, anxiety, or substance-use disorders.Methods:During the period from January 2019 to May 2019, a total of 37 patients with TRS and 37 control without autoimmune disease non-pregnant were included in this study. All these parsons were attending the AL Hakeem General hospital, their ages grouped from (18-70) years. Male to Female ratio 1/1. Erythrocyte Sedimentation Rate (ESR), White Blood Cell Count to prove all participants in this study free from infectious disease for exclusion criteria. IL6, IL18 and FH-125 in serum samples were measured by (ELISA).
Reference7 articles.
1. Miller A, McEvoy J, Jeste D, et al. (2006)Treatment of chronic schizophrenia. In: Lieberman J, Stroup TS, Perkins D, eds. Textbook of Schizophrenia. Washington, DC: American Psychiatric Publishing; 2006:365-381.
2. Meltzer H, Kostacoglu A.(2001) Treatment-resistant schizophrenia. In: Lieberman J, Murray R, eds. Comprehensive Care of Schizophrenia: A Textbook of Clinical Management. London: Martin Dunitz; 2001:181-203.
3. Brenner HD, Merlo MC.2000 Definition of therapy-resistant schizophrenia and its assessment. Eur Psychiatry. 2000;10(suppl 1):11s-17s.
4. Andreasen NC, Carpenter WT Jr, Kane JM, et al.(2005) Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441-449.
5. Pantelis C, Lambert TJ.2003 Managing patients with ‘‘treatment-resistant’’ schizophrenia. Med J Aust. 2003;178(suppl):S62-S66.